Alliances
Expesicor announced an official collaboration agreement with Novoron Bioscience, a private, San Diego-based biotechnology company developing novel therapeutic approaches to address disorders of the central nervous system.
EpiCypher® announced the signing of an agreement with Thermo Fisher Scientific, the world leader in servicing science, to provide co-exclusive use of EpiCypher’s SNAP-ChIP® technology.
ADC Therapeutics to develop next-generation masked antibody drug conjugates (ADCs), incorporating Adagene’s SAFEbody™ technology, with potential utility across multiple tumor types
Companies across Europe and Asia provide information about deal, clinical trials and more, with news from Synaptive Medical, Epic, Inventiva, Velabs, and more.
ADC Therapeutics, based in Lausanne, Switzerland, and Adagene, headquartered in Suzhou, China and San Francisco, announced a discovery collaboration and license deal.
The two companies will combine their expertise to drive new immunology candidates toward the clinic.
Swiss pharma giant Novartis supported the company’s Series C financing round with a $75 million equity investment.
Contributing to the development of maternal and child health, and medical information in Kenya
The BioIT World Conference & Expo is going on in Boston, Massachusetts, highlighting companies and breakthroughs working on the data end of life sciences, whether that’s blockchain, artificial intelligence, machine learning, data science, deep learning or others.
Pharma and biotechs from across the globe share news, pipeline updates, with stories from Vetter, Atomwise, Tessa, GenSight, and more.
PRESS RELEASES